Skip to main content
. 2021 Aug 31;41(9):1350–1357. [Article in Chinese] doi: 10.12122/j.issn.1673-4254.2021.09.09

2.

混合菌PDAP与对照组基线资料比较

Comparison of the clinical data between the two groups

Items Polymicrobial PDAP (n=79) Control (n=735) P
WBC: White blood cell; HB: Hemoglobin; ALB: Albumin; eGFR: Estimated glomerular filtration rate; PDAP: Peritoneal dialysis associated peritonitis.
Female (%) 45 (57.0) 369 (50.2) 0.287
Age (year) 59.0 (49.0, 72.0) 58.0 (47.0, 68.0) 0.283
  Elderly patients (%) 38 (48.1) 248 (33.7) 0.013
Protopathy (%)
  Glomerulonephritis 32 (40.5) 302 (41.1) 1.000
  Diabetic Nephropathy 19 (24.1) 188 (25.6) 0.788
  Polycystic kidney 5 (6.3) 38 (5.2) 0.598
  Hypertensive nephropathy 11 (13.9) 109 (14.8) 0.870
  Interstitial nephritis 4 (5.1) 30 (4.1) 0.563
Accompanying disease (%)
  Cardiovascular disease 35 (44.3) 247 (33.6) 0.063
  Diabetes 25 (31.6) 263 (35.8) 0.536
Dialysis age (Month) 13.0 (7.0, 34.0) 16.0 (6.0, 31.0) 0.679
WBC (×109 /L) 9.4 (7.3, 12.5) 9.5±5.4 0.104
HB (g/L) 101.5±25.7 98.7±18.9 0.437
ALB (g/L) 28.9±5.5 28.4±5.9 0.983
Serum creatinine (μmol/L) 722.0 (550.0, 904.8) 741.4±264.6 0.798
eGFR (mL/min/1.73 m2) 5.6 (4.2, 7.1) 5.8 (4.5, 7.7) 0.183
Ascites leukocyte (the first day) (×106/L) 4320 (1250.0, 8000.0) 2400 (841.5, 5624.3) 0.030
Refractory PDAP (%) 30 (38.0) 162 (22.0) 0.002
Antibiotic treatment courses (d) 13.0 (10.0, 17.0) 12.0 (8.0, 15.0) 0.016